1型神经纤维瘤-话题@MedSci

#1型神经纤维瘤#

9篇内容 | 1240人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1510784, encodeId=2f5d1510e843b, content=<a href='/topic/show?id=9acc6e0f7' target=_blank style='color:#2F92EE;'>#1型神经纤维瘤#</a>, objectTitle=Neuro-Oncology：用于1型神经纤维瘤病的MEK抑制剂的临床证据和共识, objectType=article, longId=732817, objectId=fd3ce32817fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fd3ce32817fa, replyNumber=0, likeNumber=100, createdTime=2022-07-21, rootId=0, userName=paperyu, userId=6f0f10248147, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd3ce32817fa, moduleTitle=Neuro-Oncology：用于1型神经纤维瘤病的MEK抑制剂的临床证据和共识, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fd3ce32817fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510783, encodeId=c64c1510e830d, content=<a href='/topic/show?id=9acc6e0f7' target=_blank style='color:#2F92EE;'>#1型神经纤维瘤#</a>, objectTitle=NICE推荐Koselugo用于治疗1型神经纤维瘤病, objectType=article, longId=723938, objectId=6925e2393821, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6925e2393821, replyNumber=0, likeNumber=94, createdTime=2022-04-11, rootId=0, userName=paperyu, userId=6f0f10248147, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6925e2393821, moduleTitle=NICE推荐Koselugo用于治疗1型神经纤维瘤病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6925e2393821)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510782, encodeId=b5df1510e8223, content=<a href='/topic/show?id=9acc6e0f7' target=_blank style='color:#2F92EE;'>#1型神经纤维瘤#</a>, objectTitle=AJRCCM：什么是1型神经纤维瘤病相关肺动脉高压？, objectType=article, longId=219521, objectId=b4f92195219a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b4f92195219a, replyNumber=0, likeNumber=99, createdTime=2021-10-31, rootId=0, userName=paperyu, userId=6f0f10248147, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b4f92195219a, moduleTitle=AJRCCM：什么是1型神经纤维瘤病相关肺动脉高压？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b4f92195219a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510781, encodeId=5fc21510e8184, content=<a href='/topic/show?id=9acc6e0f7' target=_blank style='color:#2F92EE;'>#1型神经纤维瘤#</a>, objectTitle=JAMA Netw Open：1型神经纤维瘤病患者发生多种肿瘤的风险均明显增加！, objectType=article, longId=208724, objectId=335e208e240d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=335e208e240d, replyNumber=0, likeNumber=105, createdTime=2021-03-21, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=335e208e240d, moduleTitle=JAMA Netw Open：1型神经纤维瘤病患者发生多种肿瘤的风险均明显增加！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=335e208e240d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510780, encodeId=24c31510e80b2, content=<a href='/topic/show?id=9acc6e0f7' target=_blank style='color:#2F92EE;'>#1型神经纤维瘤#</a>, objectTitle=Acta Neuropathologica: 儿童1型神经纤维瘤病（NF1）低级别胶质瘤的分子和临床分析, objectType=article, longId=208516, objectId=59a120851645, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=59a120851645, replyNumber=0, likeNumber=80, createdTime=2021-03-18, rootId=0, userName=paperyu, userId=6f0f10248147, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=59a120851645, moduleTitle=Acta Neuropathologica: 儿童1型神经纤维瘤病（NF1）低级别胶质瘤的分子和临床分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=59a120851645)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510779, encodeId=58281510e7967, content=<a href='/topic/show?id=9acc6e0f7' target=_blank style='color:#2F92EE;'>#1型神经纤维瘤#</a>, objectTitle=FDA批准Koselugo作为美国最佳治疗儿童1型神经纤维瘤的药物, objectType=article, longId=192011, objectId=06fc192011c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=06fc192011c7, replyNumber=0, likeNumber=83, createdTime=2020-04-12, rootId=0, userName=paperyu, userId=6f0f10248147, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=06fc192011c7, moduleTitle=FDA批准Koselugo作为美国最佳治疗儿童1型神经纤维瘤的药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=06fc192011c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510778, encodeId=1a2e1510e78c3, content=<a href='/topic/show?id=9acc6e0f7' target=_blank style='color:#2F92EE;'>#1型神经纤维瘤#</a>, objectTitle=EMA授予AZ和MSD公司MEK抑制剂孤儿药资格用于治疗1型神经纤维瘤, objectType=article, longId=145835, objectId=24c4145835bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=24c4145835bc, replyNumber=0, likeNumber=74, createdTime=2018-08-05, rootId=0, userName=paperyu, userId=6f0f10248147, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=24c4145835bc, moduleTitle=EMA授予AZ和MSD公司MEK抑制剂孤儿药资格用于治疗1型神经纤维瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=24c4145835bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510777, encodeId=46611510e7755, content=<a href='/topic/show?id=9acc6e0f7' target=_blank style='color:#2F92EE;'>#1型神经纤维瘤#</a>, objectTitle=Semin Pediatr Neurol：1型神经纤维瘤继发性视神经胶质瘤综述！, objectType=article, longId=114217, objectId=45ad11421ee0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=45ad11421ee0, replyNumber=0, likeNumber=71, createdTime=2017-09-27, rootId=0, userName=paperyu, userId=6f0f10248147, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=45ad11421ee0, moduleTitle=Semin Pediatr Neurol：1型神经纤维瘤继发性视神经胶质瘤综述！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=45ad11421ee0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510776, encodeId=d5011510e7607, content=<a href='/topic/show?id=9acc6e0f7' target=_blank style='color:#2F92EE;'>#1型神经纤维瘤#</a>, objectTitle=Lancet Neurol：辛伐他汀对1型神经纤维瘤病患儿无效, objectType=article, longId=25615, objectId=f3ee2561559, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f3ee2561559, replyNumber=0, likeNumber=77, createdTime=2013-10-23, rootId=0, userName=paperyu, userId=6f0f10248147, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f3ee2561559, moduleTitle=Lancet Neurol：辛伐他汀对1型神经纤维瘤病患儿无效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f3ee2561559)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

1型神经纤维瘤

2020-05-29

paperyu (审核中...)

前往app查看评论内容

#1型神经纤维瘤#

Neuro-Oncology：用于1型神经纤维瘤病的MEK抑制剂的临床证据和共识

2022-07-21

paperyu (审核中...)

前往app查看评论内容

#1型神经纤维瘤#

NICE推荐Koselugo用于治疗1型神经纤维瘤病

2022-04-11

paperyu (审核中...)

前往app查看评论内容

#1型神经纤维瘤#

AJRCCM：什么是1型神经纤维瘤病相关肺动脉高压？

2021-10-31

仁者大医 (审核中...)

前往app查看评论内容

#1型神经纤维瘤#

JAMA Netw Open：1型神经纤维瘤病患者发生多种肿瘤的风险均明显增加！

2021-03-21

paperyu (审核中...)

前往app查看评论内容

#1型神经纤维瘤#

Acta Neuropathologica: 儿童1型神经纤维瘤病（NF1）低级别胶质瘤的分子和临床分析

2021-03-18

paperyu (审核中...)

前往app查看评论内容

#1型神经纤维瘤#

FDA批准Koselugo作为美国最佳治疗儿童1型神经纤维瘤的药物

2020-04-12

paperyu (审核中...)

前往app查看评论内容

#1型神经纤维瘤#

EMA授予AZ和MSD公司MEK抑制剂孤儿药资格用于治疗1型神经纤维瘤

2018-08-05

paperyu (审核中...)

前往app查看评论内容

#1型神经纤维瘤#

Semin Pediatr Neurol：1型神经纤维瘤继发性视神经胶质瘤综述！

2017-09-27

paperyu (审核中...)

前往app查看评论内容

#1型神经纤维瘤#

Lancet Neurol：辛伐他汀对1型神经纤维瘤病患儿无效

2013-10-23

科室
- - 订阅+
  - 更多科室
工具
服务